Agreement between procalcitonin measurements using the new point-of-care testing ichroma™ reader and the automated Kryptor instrument
- 15 May 2019
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Laboratory Medicine
- Vol. 43 (3) , 169-172
Abstract
Background To evaluate if procalcitonin (PCT) measurements made using the new point-of-care testing (POCT) ichroma™ are interchangeable with those made using Kryptor. Methods Serum samples (n = 117) were processed sequentially on Kryptor and ichroma™. Statistical analysis was performed using Passing-Bablok (PB) regression and the Bland-Altman (BA) test. Cohen’s kappa statistic was used to calculate the concordance at the clinically relevant cutoffs. Results PB regression did not show a significant deviation from linearity; proportional and constant differences were observed between ichroma™ and Kryptor. The 95% confidence interval (CI) of the mean bias percentage was very large, exceeding the maximum allowable total error (TE) (approximately 20%) and the clinical reference change value (about 60%). However, the concordance between methods at the clinically relevant cutoffs was strong, with the exception of the 0.25 ng/mL cutoff, which was moderate. Conclusions Our data suggest that ichroma™ is not interchangeable with Kryptor, so cannot be mixed; one must choose one instrument only and be consistent. However, while the strong concordance at the clinically relevant cutoffs allows us to consider ichroma™ a suitable option to Kryptor to support clinicians’ decision-making, nevertheless the moderate agreement at the 0.25 ng/mL cutoff recommends caution in interpreting the data around this cutoff.Keywords
This publication has 10 references indexed in Scilit:
- Procalcitonin-guided antibiotic therapy: an expert consensusClinical Chemistry and Laboratory Medicine (CCLM), 2018
- Procalcitonin guidance in patients with lower respiratory tract infections: a systematic review and meta-analysisClinical Chemistry and Laboratory Medicine (CCLM), 2018
- Procalcitonin-guided diagnosis and antibiotic stewardship revisitedBMC Medicine, 2017
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Intensive Care Medicine, 2017
- Using Procalcitonin to Guide Antibiotic TherapyOpen Forum Infectious Diseases, 2016
- Diagnosing sepsis – The role of laboratory medicineClinica Chimica Acta, 2016
- Assessment of Global Incidence and Mortality of Hospital-treated Sepsis: Current Estimates and LimitationsAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Bedside procalcitonin and acute careInternational Journal of Critical Illness and Injury Science, 2014
- Method comparison: where do we draw the line?Clinical Chemistry and Laboratory Medicine (CCLM), 2011
- Biological Variation of Procalcitonin in Healthy IndividualsClinical Chemistry, 2004